Get the Stockscreener App
1.20
0.84%
0.01
After Hours:
1.21
0.01
+0.83%
Opko Health Inc stock is traded at $1.20, with a volume of 1.43M.
It is up +0.84% in the last 24 hours and down -4.00% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
See More
Previous Close:
$1.19
Open:
$1.21
24h Volume:
1.43M
Relative Volume:
0.46
Market Cap:
$921.24M
Revenue:
$642.03M
Net Income/Loss:
$-180.42M
P/E Ratio:
-4.8642
EPS:
-0.2467
Net Cash Flow:
$-212.06M
1W Performance:
+1.69%
1M Performance:
-4.00%
6M Performance:
-13.04%
1Y Performance:
-37.50%
1-Day Range:
$1.19
$1.22
1-Week Range:
$1.16
$1.26
52-Week Range:
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.20 | 913.56M | 642.03M | -180.42M | -212.06M | -0.2467 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-25 | Initiated | JP Morgan | Neutral |
| Oct-31-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-25-25 | Initiated | JP Morgan | Neutral |
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
Opko Health, Inc. (OPK) Stock Analysis: Exploring a 174% Potential Upside Amidst Challenging Fundamentals - DirectorsTalk Interviews
OPK PE Ratio & Valuation, Is OPK Overvalued - Intellectia AI
OPKO Health (NASDAQ:OPK) Given New $1.50 Price Target at Barrington Research - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Q4 2025 Earnings Call Transcript - Insider Monkey
OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives - Sahm
OPK Should I Buy - Intellectia AI
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts - Yahoo Finance
OPKO Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit - ChartMill
OPKO Health Q4 Earnings Call Highlights - MarketBeat
OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ... By GuruFocus - Investing.com Canada
OPKO Health (NASDAQ:OPK) Announces Earnings Results - MarketBeat
OPKO Health (OPK) Q4 2025 Earnings Call Transcript - The Globe and Mail
OPKO Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics - Nasdaq
OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: OPKO Health beats Q4 2025 EPS forecast, stock dips - Investing.com
OPKO Health: Q4 Earnings Snapshot - marketscreener.com
OPKO Health Q4 revenue falls - TradingView
Earnings Breakdown: OPKO Health Q4 - Benzinga
OPK: Q4 2025 saw lower revenues and a net loss, but strong R&D progress and new partnerships - TradingView
OPKO Health (NASDAQ: OPK) restructures labs, leans on NGENLA and 4Kscore growth - Stock Titan
OPKO Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2026 and for the Year Ending December 31, 2026 - marketscreener.com
Income Statement - OPKO Health, Inc.
OPKO Health: Fourth Quarter Financial Overview - Bitget
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results - Bitget
OPKO Health Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Opko Health, Inc. (OPK) Stock Analysis: A Closer Look At Its 209% Potential Upside - DirectorsTalk Interviews
Revenue Check: Is OPKO Health Inc likely to announce a buyback2025 Performance Recap & Growth Focused Entry Reports - baoquankhu1.vn
Brokerages Set OPKO Health, Inc. (NASDAQ:OPK) Target Price at $2.28 - Defense World
Total debt per share of OPKO Health, Inc. – LSE:0KCS - TradingView
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - The Globe and Mail
OPKO Health (OPK) Projected to Post Quarterly Earnings on Thursday - MarketBeat
MSN Money - MSN
Can OPKO Health's pipeline progress and deals drive growth in 2026? - MSN
Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation - Finviz
Opko Health, Inc. (OPK) Investor Outlook: Unpacking The 189.30% Potential Upside - DirectorsTalk Interviews
11 Best High Return Penny Stocks to Buy Right Now - Insider Monkey
Esoteric Testing Market: Generated Opportunities and Future - openPR.com
Why OPKO Health Inc. stock is favored by top institutionsJuly 2025 Snapshot & Accurate Buy Signal Notifications - mfd.ru
OPKO Health, Inc. to Announce 2025 Financial Results on February 26, 2026 - Quiver Quantitative
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 - OPKO Health, Inc.
What is the long term forecast for OPKO Health Inc. stockWall Street Watch & AI Enhanced Trade Execution Alerts - mfd.ru
OPKO Health Insider Ups Holding During Year - Yahoo Finance
What hedge fund activity signals for OPKO Health Inc. stock2025 Price Targets & Real-Time Stock Price Movement Reports - mfd.ru
Opko Health stock rating reiterated at Buy by H.C. Wainwright - Investing.com Canada
OPKO Health, Inc. (OPK) Stock Analysis: Exploring A 191.67% Potential Upside - DirectorsTalk Interviews
Swing Trade: What is OPKO Health Incs 5 year growth outlookWeekly Risk Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Opko Health (OPK) Expands Entera Partnership for Drug Co-Development - Insider Monkey
11 Best Stocks Under $3 to Buy Right Now - Insider Monkey
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):